IVD原材料の世界市場

IVD原材料の世界市場は2030年までに358億米ドルに到達

2024年に277億米ドルと推定されるIVD原材料の世界市場は、分析期間2024-2030年にCAGR 4.3%で成長し、2030年には358億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるIVD抗体・抗原は、CAGR 3.8%を記録し、分析期間終了時には130億米ドルに達すると予測されます。IVD酵素分野の成長率は、分析期間中CAGR 5.0%と推定されます。

米国市場は76億米ドルと推定、中国はCAGR 7.8%で成長予測

米国のIVD原材料市場は2024年に76億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに73億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは7.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と3.4%と予測されています。欧州では、ドイツがCAGR 2.5%で成長すると予測されています。

世界のIVD原材料市場- 主要動向と促進要因まとめ

体外診断薬の信頼性において原材料が果たす役割とは？

IVD原材料とは、体外診断用検査やキットの製造に使用される必須の生物学的、化学的、合成成分を指します。抗体、抗原、酵素、ヌクレオチド、試薬、緩衝液、安定剤、対照物質などが含まれます。これらの原材料の品質、一貫性、性能は、疾患の検出、モニタリング、スクリーニングに使用される診断アッセイの感度、特異性、再現性に直接影響します。

分子診断、ポイントオブケア検査、感染症サーベイランスの増加に伴い、信頼性の高いIVD原材料に対する需要が急増しています。製造業者は、規制遵守とアッセイの信頼性を確保するために、高純度でロットの揃った原材料を調達する必要に迫られています。バイオテクノロジー企業や研究開発も、腫瘍学、心臓病学、感染症学における新しい検査フォーマットの開発において、IVDグレードの原材料に依存しています。

どのような革新が材料調達と品質保証を変革しているか？

IVD原材料のサプライヤーは、厳しい品質基準を満たすために、高度な精製プロセス、発現システム、組み換え生産技術に投資しています。モノクローナル抗体生産、合成ペプチド合成、酵素工学は、高収率で再現性のあるバッチを提供するために改良されています。組換え抗原や核酸プローブは、高精度の検査キットにおいて、変動しやすい生物学的材料の代わりに使用されつつあります。

材料サプライヤーはまた、安定性試験、性能文書化、トレーサブルなロット記録を備えたバリデーション済みの原材料を提供し、IVDメーカーによる規制当局への申請を合理化しています。信頼性が高く、拡張性があり、監査に対応できるサプライヤーを検査開発者が求める中、GMP準拠の製造、ISO認証、世界の流通能力は必須条件となりつつあります。公衆衛生上の危機や需要急増の際にも供給が途切れないよう、垂直統合型の生産ラインを開発する会社もあります。

需要の集中場所と主要バイヤーは？

需要は診断キットメーカー、分子検査開発企業、標準検査機関の間で最も強いです。PCRベースの診断薬、ELISAキット、ラテラルフローアッセイ、シークエンシングプラットフォームを開発する企業は、特定の検出ターゲットに合わせた幅広い原材料に依存しています。研究機関やバイオテクノロジー企業も、アッセイ開発や臨床バリデーションのためにIVDグレードの原材料を購入しています。

北米と欧州は診断薬企業が集中し、規制が厳しいため、依然として主要市場です。アジア太平洋地域は、現地生産への取り組み、疾病サーベイランスの拡大、輸出能力の増加により急成長しています。公衆衛生研究所、学術機関、受託診断メーカーは、世界の診断能力の拡大に伴い、原材料の使用量を拡大しています。

IVD原材料市場の成長の原動力は？

IVD原材料市場の成長は、診断検査に対する世界の需要の高まり、アッセイフォーマットの複雑化、原材料の品質に対する規制当局の監視強化など、いくつかの要因によって牽引されています。組換え生産、合成化学、発現システムの進歩により、高性能コンポーネントの信頼性が高くスケーラブルな供給が可能になっています。

分子診断、感染症検査、個別化医療における最終用途の拡大により、高度に特異的で安定した原材料に対する需要が繰り返し生じています。新しい病原体の出現、分散型検査への注目、ラボのインフラへの投資の増加は、使用量をさらに押し上げています。診断学が予防医療や精密医療の中心となるにつれ、高品質のIVD原材料に対するニーズは、既存のヘルスケア市場でも新興ヘルスケア市場でも高まり続けています。

セグメント

製品（体外診断用医薬品抗体・抗原、体外診断用医薬品酵素、体外診断用医薬品タンパク質、体外診断用医薬品生物学的緩衝液、その他製品）、技術（臨床化学技術、免疫化学技術、分子診断技術、その他技術）、エンドユーザー（製薬・バイオテクノロジー企業エンドユーザー、診断ラボエンドユーザー、その他エンドユーザー）

調査対象企業の例

• Aalto Bio Reagents Ltd.
• AMSBIO（AMS Biotechnology）
• BBI Solutions
• Bio-Rad Laboratories, Inc.
• Bio-Check（UK）Ltd
• Bioporto Diagnostics
• Diarect AG
• EastCoast Bio
• Fitzgerald Industries Intl.
• Fujirebio
• HyTest Ltd
• Jena Bioscience GmbH
• Medix Biochemica
• Meridian Bioscience, Inc.
• MyBiosource, Inc.
• QuidelOrtho Corporation
• RayBiotech, Inc.
• Rockland Immunochemicals, Inc.
• Scripps Laboratories, Inc.
• Sekisui Diagnostics

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global IVD Raw Materials Market to Reach US$35.8 Billion by 2030

The global market for IVD Raw Materials estimated at US$27.7 Billion in the year 2024, is expected to reach US$35.8 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. IVD Antibody & Antigens, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$13.0 Billion by the end of the analysis period. Growth in the IVD Enzymes segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 7.8% CAGR

The IVD Raw Materials market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global IVD Raw Materials Market - Key Trends & Drivers Summarized

What Role Do Raw Materials Play in the Reliability of In Vitro Diagnostics?

IVD raw materials refer to the essential biological, chemical, and synthetic components used in the manufacture of in vitro diagnostic tests and kits. These include antibodies, antigens, enzymes, nucleotides, reagents, buffers, stabilizers, and control materials. The quality, consistency, and performance of these raw inputs directly impact the sensitivity, specificity, and reproducibility of diagnostic assays used for disease detection, monitoring, and screening.

Demand for reliable IVD raw materials has surged with the rise in molecular diagnostics, point-of-care testing, and infectious disease surveillance. Manufacturers are under pressure to source high-purity, lot-consistent raw materials to ensure regulatory compliance and assay reliability. Biotech firms and research labs also depend on IVD-grade materials for developing new test formats in oncology, cardiology, and infectious diseases.

What Innovations Are Transforming Material Sourcing and Quality Assurance?

Suppliers of IVD raw materials are investing in advanced purification processes, expression systems, and recombinant production technologies to meet stringent quality standards. Monoclonal antibody production, synthetic peptide synthesis, and enzyme engineering are being refined to deliver high-yield, reproducible batches. Recombinant antigens and nucleic acid probes are being used to replace variable biological materials in high-precision test kits.

Material suppliers are also offering pre-validated raw inputs with stability testing, performance documentation, and traceable lot records to streamline regulatory filings by IVD manufacturers. GMP-compliant manufacturing, ISO certifications, and global distribution capabilities are becoming prerequisites as test developers seek reliable, scalable, and audit-ready suppliers. Some companies are developing vertically integrated production lines to ensure uninterrupted supply during public health crises or demand surges.

Where Is Demand Concentrated, and Who Are the Leading Buyers?

Demand is strongest among diagnostic kit manufacturers, molecular test developers, and reference laboratories. Companies developing PCR-based diagnostics, ELISA kits, lateral flow assays, and sequencing platforms rely on a wide range of raw materials tailored to specific detection targets. Research organizations and biotech firms also purchase IVD-grade materials for assay development and clinical validation.

North America and Europe remain key markets due to the concentration of diagnostics firms and regulatory stringency. Asia Pacific is growing rapidly, driven by local manufacturing initiatives, expanding disease surveillance, and increasing export capacity. Public health laboratories, academic institutions, and contract diagnostic manufacturers are expanding their raw material usage as global diagnostic capacity grows.

What Is Driving Growth in the IVD Raw Materials Market?

Growth in the IVD raw materials market is driven by several factors including rising global demand for diagnostic testing, increasing complexity of assay formats, and heightened regulatory scrutiny of material quality. Advances in recombinant production, synthetic chemistry, and expression systems are enabling reliable, scalable supply of high-performance components.

End-use expansion in molecular diagnostics, infectious disease testing, and personalized medicine is creating recurring demand for highly specific and stable raw materials. Emergence of new pathogens, focus on decentralized testing, and growing investment in lab infrastructure are further boosting usage. As diagnostics become central to preventive and precision medicine, the need for high-quality IVD raw materials continues to grow in both established and emerging healthcare markets.

SCOPE OF STUDY:

The report analyzes the IVD Raw Materials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers, Other Products); Technology (Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology, Other Technologies); End-Use (Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

• Aalto Bio Reagents Ltd.
• AMSBIO (AMS Biotechnology)
• BBI Solutions
• Bio-Rad Laboratories, Inc.
• Bio-Check (UK) Ltd
• Bioporto Diagnostics
• Diarect AG
• EastCoast Bio
• Fitzgerald Industries Intl.
• Fujirebio
• HyTest Ltd
• Jena Bioscience GmbH
• Medix Biochemica
• Meridian Bioscience, Inc.
• MyBiosource, Inc.
• QuidelOrtho Corporation
• RayBiotech, Inc.
• Rockland Immunochemicals, Inc.
• Scripps Laboratories, Inc.
• Sekisui Diagnostics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • IVD Raw Materials - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for In Vitro Diagnostics Across Infectious Disease, Cancer, and Genetic Testing Drives Consumption of Raw Materials
  • Expansion of Point-of-Care and Home Diagnostics Strengthens Need for High-Quality Antibodies, Antigens, and Buffers
  • OEM Focus on Recombinant Protein Engineering and Monoclonal Antibody Production Enhances Specificity and Stability
  • Growth in Molecular Diagnostics and PCR-Based Assays Throws Spotlight on High-Fidelity Enzymes and Primers
  • Increasing Emphasis on Supply Chain Resilience and Material Traceability Supports Strategic Sourcing of IVD Inputs
  • OEM Investment in GMP-Compliant Raw Material Manufacturing Improves Quality Assurance for Diagnostic Kit Producers
  • Rising Adoption of Multiplex Assays and Rapid Diagnostic Tests Fuels Need for Custom Coating and Blocking Reagents
  • OEM Development of Bulk Supply Agreements With Test Kit Manufacturers Enhances Scalability and Delivery Reliability
  • Growth in Companion Diagnostics and Personalized Medicine Expands Use of Specialized Biomarker Reagents
  • OEM Innovation in Lyophilized and Room-Temperature Stable Raw Materials Supports Distribution in Low-Resource Settings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World IVD Raw Materials Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for IVD Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for IVD Antibody & Antigens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for IVD Antibody & Antigens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for IVD Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for IVD Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for IVD Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for IVD Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for IVD Biological Buffers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for IVD Biological Buffers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Immunochemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Immunochemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• JAPAN
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• CHINA
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• EUROPE
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for IVD Raw Materials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• FRANCE
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• GERMANY
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for IVD Raw Materials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• AUSTRALIA
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• INDIA
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for IVD Raw Materials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for IVD Raw Materials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for IVD Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
• AFRICA
  • IVD Raw Materials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for IVD Raw Materials by Product - IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for IVD Raw Materials by Product - Percentage Breakdown of Value Sales for IVD Antibody & Antigens, IVD Enzymes, IVD Proteins, IVD Biological Buffers and Other Products for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for IVD Raw Materials by End-Use - Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for IVD Raw Materials by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Diagnostic Laboratories End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for IVD Raw Materials by Technology - Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for IVD Raw Materials by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunochemistry Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030

IV. COMPETITION